Horizon Acquisition Corp II (HZON) 10-K 16 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 16, 2022	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Entity Registrant Name	HORIZON ACQUISITION CORPORATION II
Transition Report	false
Entity Incorporation, State or Country Code	E9
Entity File Number	001-39631
Entity Tax Identification Number	98-1553406
Entity Address, Address Line One	600 Steamboat Road
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Greenwich
Entity Address State Or Province	CT
Entity Address, Postal Zip Code	06830
City Area Code	203
Local Phone Number	298-5300
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Central Index Key	0001821788
Amendment Flag	false
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float			$ 361,490,000
Document Annual Report	true
Auditor Name	WithumSmith+Brown
Auditor Firm ID	100
Auditor Location	New York, New York
Class A ordinary shares
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	HZON
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		52,500,000
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	HZON WS
Security Exchange Name	NYSE
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Trading Symbol	HZON.U
Security Exchange Name	NYSE
Class B ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		13,125,000

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 380,457	$ 823,192
Prepaid expenses	227,199	510,017
Total current assets	607,656	1,333,209
Investments held in Trust Account	525,037,813	525,003,145
Total Assets	525,645,469	526,336,354
Current liabilities:
Accounts payable	48,733	6,000
Accrued expenses	2,436,117	208,037
Total current liabilities	2,484,850	214,037
Derivative warrant liabilities	22,103,000	45,156,670
Deferred underwriting commissions	12,950,000	12,950,000
Total Liabilities	37,537,850	58,320,707
Commitments and Contingencies (Note 6)
Shareholders' Deficit:
Preference shares, $0.0001 par value 1,000,000 shares authorized none issued or outstanding
Accumulated deficit	(36,893,694)	(56,985,666)
Total Shareholders' Deficit	(36,892,381)	(56,984,353)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	525,645,469	526,336,354
Class A Ordinary Shares subject to redemption
Current liabilities:
Class A ordinary shares subject to possible redemption; 52,500,000 at December 31,2021 and 2020 (at redemption value of $10.00 per share)	525,000,000	525,000,000
Class B ordinary shares
Shareholders' Deficit:
Ordinary shares	$ 1,313	$ 1,313

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Preference shares, par value	$ 0.0001	$ 0.0001
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, shares issued	0	0
Preference shares, shares outstanding	0	0
Class A ordinary shares
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, authorized shares	400,000,000	400,000,000
Number of shares subject to possible redemption	52,500,000	52,500,000
Class A Ordinary Shares subject to redemption
Number of shares subject to possible redemption	52,500,000	52,500,000
Shares subject to possible redemption, par value per share	$ 10	$ 10
Class A Non-redeemable Ordinary Shares
Ordinary shares, shares issued	0	0
Ordinary shares, shares outstanding	0	0
Class B ordinary shares
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, authorized shares	40,000,000	40,000,000
Ordinary shares, shares issued	13,125,000	13,125,000
Ordinary shares, shares outstanding	13,125,000	13,125,000

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
General and administrative expenses	$ 249,892	$ 2,997,246
Loss from operations	(249,892)	(2,997,246)
Other income (expenses):
Change in fair value of derivative warrant liabilities	(9,269,010)	23,053,670
Financing cost - derivative warrant liabilities	(1,067,843)
Interest income		880
Net gain from investments held in Trust Account	3,144	34,668
Net income (loss)	$ (10,583,601)	$ 20,091,972
Class A ordinary shares
Other income (expenses):
Basic weighted average shares outstanding	24,744,898	52,500,000
Diluted weighted average shares outstanding	24,744,898	52,500,000
Basic net loss per share	$ (0.28)	$ 0.31
Diluted net loss per share	$ (0.28)	$ 0.31
Class B ordinary shares
Other income (expenses):
Basic weighted average shares outstanding	12,648,810	13,125,000
Diluted weighted average shares outstanding	12,648,810	13,125,000
Basic net loss per share	$ (0.28)	$ 0.31
Diluted net loss per share	$ (0.28)	$ 0.31

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT	Class A ordinary sharesOrdinary SharesUSD ($)shares	Class A ordinary sharesOrdinary SharesUSS ($)shares	Class B ordinary sharesOrdinary SharesUSD ($)shares	Additional Paid-in CapitalUSD ($)	Accumulated DeficitUSD ($)	USD ($)
Balance at the beginning at Jul. 21, 2020 | $	$ 0		$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Jul. 21, 2020 | shares	0	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor | $	$ 0		$ 1,438	23,562		25,000
Issuance of Class B ordinary shares to Sponsor (in shares) | shares	0	0	14,375,000
Excess of fair value of private placement warrants over cash received	$ 0	$ 0		(23,687)	(38,973)	(62,660)
Forfeiture of Class B ordinary shares | $	$ 0		$ (125)	125
Forfeiture of Class B ordinary shares (in shares) | shares	0	0	(1,250,000)
Accretion of Class A ordinary shares subject to redemption to redemption amount | $	$ 0				(46,363,092)	(46,363,092)
Accretion of Class A ordinary shares subject to redemption to redemption amount (in shares) | shares	0	0
Net income (loss)	$ 0	$ 0			(10,583,601)	(10,583,601)
Balance at the end at Dec. 31, 2020 | $	$ 0		$ 1,313	0	(56,985,666)	(56,984,353)
Balance at the end (in shares) at Dec. 31, 2020 | shares	0	0	13,125,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0		0	20,091,972	20,091,972
Balance at the end at Dec. 31, 2021 | $	$ 0		$ 1,313	$ 0	$ (36,893,694)	$ (36,892,381)
Balance at the end (in shares) at Dec. 31, 2021 | shares	0	0	13,125,000

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (10,583,601)	$ 20,091,972
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	9,269,010	(23,053,670)
Financing cost - derivative warrant liabilities	1,067,843
Net (gain) loss from investments held in Trust Account	(3,144)	(34,668)
Changes in operating assets and liabilities:
Prepaid expenses	(485,017)	282,818
Accounts payable	(392,251)	42,733
Accrued expenses	123,037	2,228,080
Net cash used in operating activities	(1,004,123)	(442,735)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(525,000,000)
Net cash used in investing activities	(525,000,000)
Cash Flows from Financing Activities:
Borrowings under note payable to Sponsor	(161,385)
Proceeds received from initial public offering, gross	525,000,000
Proceeds received from private placement	9,400,000
Offering costs paid	(7,411,300)
Net cash provided by financing activities	526,827,315
Net (decrease) increase in cash	823,192	(442,735)
Cash - beginning of the period	0	823,192
Cash - end of the period	823,192	$ 380,457
Supplemental disclosure of noncash investing and financing activities:
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares	25,000
Offering costs included in accounts payable	398,250
Offering costs included in accrued expenses	85,000
Offering costs paid through note payable to Sponsor	161,385
Deferred underwriting commissions	$ 12,950,000

Description of Organization, Bu

Description of Organization, Business Operations and Basis of Presentation	12 Months Ended
	Dec. 31, 2021
Description of Organization, Business Operations and Basis of Presentation
Description of Organization, Business Operations and Basis of Presentation	Note 1 - Description of Organization, Business Operations and Basis of Presentation Organization and General Horizon Acquisition Corporation II (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on July 22, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on the media and entertainment industries. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”). As of December 31, 2021, the Company had not yet commenced operations. All activity for the period from July 22, 2020 (inception) through December 31, 2021, relates to the Company’s formation and the initial public offering (the “Initial Public Offering” or “IPO”), which is described below, and since offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of investment income on investments held in the Trust Account from proceeds of its Initial Public Offering. The Company has selected December 31 as its fiscal year end. Sponsor and Initial Public Offering The Company’s sponsor is Horizon II Sponsor, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 19, 2020. On October 22, 2020, the Company consummated its Initial Public Offering of 50,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $500.0 million, and incurring offering costs of approximately $19.6 million, inclusive of approximately $12.1 million in deferred underwriting commissions (Note 6). The underwriter was granted a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 5,175,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. The underwriters exercised the over-allotment option on November 24, 2020 to purchase an additional 2,500,000 Units (the “Over-Allotment Units”), which closed on November 27, 2020 generating gross proceeds of $25.0 million (the “Over-Allotment”), and incurring additional offering costs of approximately $1.4 million in underwriting fees (inclusive of approximately $0.9 million in deferred underwriting fees). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,933,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of approximately $8.9 million (Note 4), pursuant to the Private Placement Warrants Purchase Agreement, dated October 19, 2020 (the “Private Placement Purchase Agreement”), by and between the Company and the Sponsor. The Private Placement Purchase Agreement provided for a second closing (the “Second Closing”) of the Private Placement simultaneously with the closing of the Over-Allotment Units. Accordingly, on November 27, 2020, the Second Closing of the Private Placement was consummated, resulting in the purchase of an aggregate of 333,334 Private Placement Warrants by the Sponsor, generating gross proceeds of $0.5 million. Trust Account Upon the closing of the Initial Public Offering, the Over-Allotment, and the Private Placements, a total of $525.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and Over-Allotment, and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target business or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended, or the Investment Company Act. The Company will provide the holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which was adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this Initial Public Offering (the “Initial Shareholders”) have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, October 22, 2022 (the “Combination Period”), or (B) with respect to any other provisions relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less taxes payable and up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution in the Trust Account will be less than the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. There can be no guarantee that the Company will be successful in obtaining such waivers from its targeted vendors and service providers. Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Liquidity and Going Concern As of December 31, 2021, the Company had approximately $380,000 of cash held outside of the Trust Account and a working capital deficit of approximately $1.9 million. The Company’s liquidity needs up to December 31, 2020, were satisfied through the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares (as defined in Note 5), a loan of approximately $161,000 pursuant to the Note issued to the Sponsor (Note 5). The Company repaid the Note in full on October 22, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (see Note 5). As of December 31, 2021 and 2020, there were no amounts outstanding under any Working Capital Loan. The Company has until October 22, 2022 to consummate a business combination and it is uncertain that the Company will be able to by this time. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the working capital deficit and mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2021 or 2020. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. The Company’s investments held in the Trust Account as of December 31, 2021 and 2020 are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities money market funds. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company's investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company's assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board ("FASB") ASC 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the balance sheets. As of December 31, 2021 and 2020, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, "Derivatives and Hedging" ("ASC 815"). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The change in fair value is recognized in the Company’s statements of operations. The fair value of the Public Warrants was initially measured at fair value using the Monte Carlo simulation model. Beginning as of December 31, 2020, the fair value of Public Warrants has been measured based on the listed market price of such the Public Warrants. The fair value of the Private Placement Warrants was initially and subsequently measured using a Monte Carlo simulation model. Beginning as of September 30, 2021, the fair value of the Private Placement Warrants has been measured based on the listed market price of the Public Warrants, which represent an observable market quote for a similar asset in an active market. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Offering Costs Associated with Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares upon completion of the Initial Public Offering and Over-Allotment. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require use of current assets or require the creation of current liabilities. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and 2020, 52,500,000 shares of Class A ordinary shares subject to possible redemption, respectively, are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the IPO and Over-Allotment, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2021 and 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing net income (loss) by the weighted-average number of ordinary shares outstanding for the respective periods. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 23,766,667 Class A ordinary shares in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the year ended December 31, 2021 and the period from July 22, 2020 (inception) through December 31, 2020. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Period From July 22, 2020 ​ ​ For the Year Ended December 31, ​ (Inception) through December 31, ​ ​ 2021 ​ 2020 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income (loss) ​ $ 16,073,578 ​ $ 4,018,394 ​ $ (7,003,588) ​ $ (3,580,013) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ 52,500,000 ​ 13,125,000 ​ 24,744,898 ​ 12,648,810 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.31 ​ $ 0.31 ​ $ (0.28) ​ $ (0.28) ​ Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standard Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity The Company does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2021
Initial Public Offering
Initial Public Offering	Note 3 - Initial Public Offering On October 22, 2020, the Company consummated its Initial Public Offering of 50,000,000 Units, at $10.00 per Unit, generating gross proceeds of $500.0 million, and incurring offering costs of approximately $19.6 million, inclusive of approximately $12.1 million in deferred underwriting commissions. The Sponsor purchased 15,500,000 Units (the “Sponsor IPO Units”) at the Initial Public Offering price. The underwriters did not receive any underwriting discounts or commissions on the Sponsor IPO Units. The underwriter was granted a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 5,175,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. The underwriters exercised the over-allotment option on November 24, 2020 to purchase an additional 2,500,000 Units (the “Over-Allotment Units”), which closed on November 27, 2020 generating gross proceeds of $25.0 million, and incurring additional offering costs of approximately $1.4 million in underwriting fees (inclusive of approximately $0.9 million in deferred underwriting fees). Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).

Private Placement

Private Placement	12 Months Ended
	Dec. 31, 2021
Private Placement
Private Placement	Note 4 - Private Placement Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,933,333 Private Placement Warrants to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of approximately $8.9 million. On November 27, 2020, the Second Closing of the Private Placement was consummated, resulting in the purchase of an aggregate of 333,334 Private Placement Warrants by the Sponsor, generating gross proceeds of $0.5 million. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable except as described below in Note 7 and are exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions
Related Party Transactions	Note 5 - Related Party Transactions Founder Shares On August 7, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 Class B ordinary shares (the “Founder Shares”). The Sponsor agreed to forfeit up to 1,875,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”) to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares will represent 20% of the Company’s issued and outstanding shares after the IPO. On October 22, 2020, in connection with consummation of the Sponsor IPO Units, the Sponsor surrendered 581,250 Founder Shares to the Company for no consideration, thus reducing the amount of Class B ordinary shares subject to forfeiture to 1,293,750 Class B ordinary shares. As a result of the underwriters’ partial exercise of the over-allotment option, and the remainder of the over-allotment units expiring unexercised, on December 3, 2020, 668,750 Class B ordinary shares were automatically surrendered by the Sponsor for no consideration. As of December 31, 2021 and 2020, no remaining Class B ordinary shares were subject to forfeiture. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or earlier if, subsequent to the initial Business Combination, the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, capitalization of shares, share dividends, rights issuances, subdivisions reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, and (B) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Related Party Loans On August 7, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed approximately $161,000 under the Note and fully repaid the Note on October 22, 2020. Subsequent to repayment, the facility is no longer available to the Company. In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021 and 2020, the Company had no borrowings under the Working Capital Loans. Administrative Support Agreement The Company agreed to pay the Sponsor a total of $10,000 per month, commencing on the date of listing on the NYSE, for office space, utilities, secretarial and administrative support services provided to members of the management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. From the date the securities were first listed on the NYSE through December 31, 2021, the Sponsor waived this fee. In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Audit Committee of the Board of Directors will review on a quarterly basis all payments that are made by the Company to the Sponsor, officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the Trust Account.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies
Commitments and Contingencies	Note 6 - Commitments and Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from October 16, 2020, the date of the final prospectus, related to the Initial Public Offering, to purchase up to 5,175,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On November 27, 2020, the Company issued an additional of 2,500,000 Units at the Initial Public Offering price at $10.00 per Unit pursuant to the partial exercise of the underwriters’ over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per unit (excluding the Sponsor IPO Units), or $6.9 million, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit (excluding the Affiliated Units), or $12.1 In connection with the consummation of the sale of Units pursuant to the over-allotment option on November 27, 2020, the underwriters were entitled to an additional fee of approximately $1.4 million upon closing inclusive of deferred underwriting commissions of approximately $0.9 million. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Derivative Warrant Liabilities

Derivative Warrant Liabilities	12 Months Ended
	Dec. 31, 2021
Derivative Warrant Liabilities
Derivative Warrant Liabilities	Note 7 - Derivative Warrant Liabilities As of December 31, 2021 and 2020, the Company had 17,500,000 and 6,266,667 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60 th The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 10-trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price See “— Redemption of warrants when the price per class A ordinary share equals or exceeds $18.00” and “— Redemption of warrants when the price per class A ordinary share equals or exceeds $10.00” as described below). The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except (i) that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (ii) except as described below, the Private Placement Warrants will be non-redeemable so long as they are held by the Sponsor or such its permitted transferees and (iii) the Sponsor or its permitted transferees will have the option to exercise the Private Placement Warrants on a cashless basis and have certain registration rights. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 18.00 : ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30- trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 10.00 : ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30- trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of the Class A ordinary shares for any 20 trading days within a 30- trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	12 Months Ended
	Dec. 31, 2021
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption	Note 8 — Class A Ordinary Shares Subject to Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2021, there were 52,500,000 Class A ordinary shares outstanding, which were all subject to possible redemption and are classified within temporary equity in the balance sheets. The Class A ordinary shares issued in the Initial Public Offering and issued as part of the Over-Allotment Units were recognized in Class A ordinary shares subject to possible redemption within temporary equity as follows: ​ ​ ​ ​ ​ Gross proceeds $ 525,000,000 Less: ​ Proceeds allocated to public warrants ​ (26,425,000) Class A shares offering costs ​ (19,938,092) Plus: ​ Accretion of carrying value to redemption value ​ 46,363,092 Class A ordinary shares subject to possible redemption ​ $ 525,000,000 ​

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
	Dec. 31, 2021
Shareholders' Deficit
Shareholders' Deficit	Note 9 - Shareholders’ Deficit Preference Shares — outstanding Class A Ordinary Shares — Class B Ordinary Shares — Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law; provided that only holders of Class B ordinary shares will have the right to vote on the appointment of directors prior to or in connection with the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. ​

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2021
Fair Value Measurements
Fair Value Measurements	Note 10 - Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. ​ December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active Significant Other Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets ​ ​ ​ Investments held in Trust Account ​ $ 525,037,813 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities ​ ​ ​ Derivative warrant liabilities - Public Warrants ​ $ 16,275,000 ​ $ — ​ $ — Derivative warrant liabilities - Private Warrants ​ $ — ​ $ 5,828,000 ​ $ — ​ December 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active ​ Significant Other ​ Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account ​ $ 525,003,145 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant liabilities -Public Warrants ​ $ 33,250,000 ​ $ — ​ $ — Derivative warrant liabilities -Private Warrants ​ $ — ​ $ — ​ $ 11,906,670 ​ Level 1 assets include investments in money market funds that invest in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants was initially measured at fair value using the Monte Carlo simulation model. Beginning as of December 31, 2020, the Public Warrants have been measured based on the listed market price of such warrants, a Level 1 measurement. The fair value of the Private Placement Warrants was initially and subsequently measured using a Monte Carlo simulation model. Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement to a Level 2 measurement during September 2021 was $5.6 million. As of December 31, 2021, the Private Placement Warrants transferred to Level 2 due to being measured using an observable market quote for a similar asset in an active market. For the year ended December 31, 2021, the Company recognized a gain to the statements of operations resulting from a decrease in the fair value of liabilities of approximately $23.1 million, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the period ended December 31, 2020, the Company recognized a charge to the statements of operations resulting from an increase in the fair value of liabilities of approximately $9.3 million, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary share warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2020 Volatility ​ 25.8 % Share price ​ $ 10.33 ​ Risk-free rate ​ 0.36 % Dividend yield ​ 0.0 % ​ The change in the fair value of the derivative warrant liabilities for the periods ended December 31, 2021 and 2020, is summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrants Private Warrants Total Warrant liabilities at December 31, 2020 $ 33,250,000 ​ $ 11,906,670 ​ $ 45,156,670 Change in fair value of warrant liabilities ​ $ (16,975,000) ​ $ (6,078,670) ​ $ (23,053,670) Warrant liabilities at December 31, 2021 ​ $ 16,275,000 ​ $ 5,828,000 ​ $ 22,103,000 ​

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events
Subsequent Events	Note 11 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements which have not previously been disclosed within the financial statements. ​

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2021 or 2020.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. The Company’s investments held in the Trust Account as of December 31, 2021 and 2020 are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities money market funds.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company's investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company's assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board ("FASB") ASC 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the balance sheets. As of December 31, 2021 and 2020, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, "Derivatives and Hedging" ("ASC 815"). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The change in fair value is recognized in the Company’s statements of operations. The fair value of the Public Warrants was initially measured at fair value using the Monte Carlo simulation model. Beginning as of December 31, 2020, the fair value of Public Warrants has been measured based on the listed market price of such the Public Warrants. The fair value of the Private Placement Warrants was initially and subsequently measured using a Monte Carlo simulation model. Beginning as of September 30, 2021, the fair value of the Private Placement Warrants has been measured based on the listed market price of the Public Warrants, which represent an observable market quote for a similar asset in an active market. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with Initial Public Offering	Offering Costs Associated with Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares upon completion of the Initial Public Offering and Over-Allotment. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and 2020, 52,500,000 shares of Class A ordinary shares subject to possible redemption, respectively, are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the IPO and Over-Allotment, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Income Taxes	Income Taxes FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2021 and 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing net income (loss) by the weighted-average number of ordinary shares outstanding for the respective periods. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 23,766,667 Class A ordinary shares in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the year ended December 31, 2021 and the period from July 22, 2020 (inception) through December 31, 2020. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Period From July 22, 2020 ​ ​ For the Year Ended December 31, ​ (Inception) through December 31, ​ ​ 2021 ​ 2020 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income (loss) ​ $ 16,073,578 ​ $ 4,018,394 ​ $ (7,003,588) ​ $ (3,580,013) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ 52,500,000 ​ 13,125,000 ​ 24,744,898 ​ 12,648,810 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.31 ​ $ 0.31 ​ $ (0.28) ​ $ (0.28)
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standard Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity The Company does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Summary of calculation of basic and diluted net income (loss) per ordinary share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Period From July 22, 2020 ​ ​ For the Year Ended December 31, ​ (Inception) through December 31, ​ ​ 2021 ​ 2020 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income (loss) ​ $ 16,073,578 ​ $ 4,018,394 ​ $ (7,003,588) ​ $ (3,580,013) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ 52,500,000 ​ 13,125,000 ​ 24,744,898 ​ 12,648,810 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.31 ​ $ 0.31 ​ $ (0.28) ​ $ (0.28)

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2021
Class A Ordinary Shares Subject to Possible Redemption
Schedule of ordinary shares subject to possible redemption reflected on the balance sheet	​ ​ ​ ​ ​ Gross proceeds $ 525,000,000 Less: ​ Proceeds allocated to public warrants ​ (26,425,000) Class A shares offering costs ​ (19,938,092) Plus: ​ Accretion of carrying value to redemption value ​ 46,363,092 Class A ordinary shares subject to possible redemption ​ $ 525,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Measurements
Schedule of Company's asset measured at fair value on recurring basis	​ December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active Significant Other Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets ​ ​ ​ Investments held in Trust Account ​ $ 525,037,813 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities ​ ​ ​ Derivative warrant liabilities - Public Warrants ​ $ 16,275,000 ​ $ — ​ $ — Derivative warrant liabilities - Private Warrants ​ $ — ​ $ 5,828,000 ​ $ — ​ December 31, 2020 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active ​ Significant Other ​ Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account ​ $ 525,003,145 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant liabilities -Public Warrants ​ $ 33,250,000 ​ $ — ​ $ — Derivative warrant liabilities -Private Warrants ​ $ — ​ $ — ​ $ 11,906,670 ​
Schedule of quantitative information regarding Level 3 fair value measurements	​ ​ ​ ​ ​ ​ ​ ​ December 31, 2020 Volatility ​ 25.8 % Share price ​ $ 10.33 ​ Risk-free rate ​ 0.36 % Dividend yield ​ 0.0 %
Schedule of change in the fair value of the derivative warrant liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrants Private Warrants Total Warrant liabilities at December 31, 2020 $ 33,250,000 ​ $ 11,906,670 ​ $ 45,156,670 Change in fair value of warrant liabilities ​ $ (16,975,000) ​ $ (6,078,670) ​ $ (23,053,670) Warrant liabilities at December 31, 2021 ​ $ 16,275,000 ​ $ 5,828,000 ​ $ 22,103,000

Description of Organization, _2

Description of Organization, Business Operations and Basis of Presentation (Details) - USD ($)	Nov. 27, 2020	Nov. 24, 2020	Oct. 22, 2020	Aug. 07, 2020	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Nov. 22, 2020
Subsidiary, Sale of Stock [Line Items]
Share price per share						$ 10
Offering costs					$ 7,411,300
Deferred underwriting commissions					12,950,000	$ 12,950,000	$ 12,950,000
Exercise price of warrants						$ 11.50
Cash underwriting fees						$ 6,900,000
Cash held outside the Trust Account						380,000
Working capital						$ 1,900,000
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account						80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination						50.00%
Minimum net tangible assets upon consummation of the Business Combination						$ 5,000,001
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent						15.00%
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)						100.00%
Threshold business days for redemption of public shares						10 days
Maximum net interest to pay dissolution expenses						$ 100,000
Aggregate purchase price					25,000		25,000
Loans from working capital					$ 0	0	$ 0
Sponsor | Founder Shares
Subsidiary, Sale of Stock [Line Items]
Loan from the Sponsor						$ 161,000
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Number of units issued			50,000,000
Share price per share			$ 10
Offering costs			$ 19,600,000
Deferred underwriting commissions			12,100,000
Gross proceeds			$ 500,000,000
Exercise price of warrants			$ 11.50
Initial Public Offering. | Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of units issued			15,500,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of units issued	2,500,000	2,500,000	5,175,000
Share price per share			$ 10
Offering costs	$ 1,400,000
Deferred underwriting commissions	900,000
Period granted for underwriters to exercise option			45 days
Gross proceeds	25,000,000
Cash underwriting fees	$ 1,400,000
Private Placement.
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued			5,933,333
Share price per share			$ 1.50
Proceeds from sale of Private Placement Warrants			$ 8,900,000
Private Placement. | Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	333,334
Proceeds from sale of Private Placement Warrants	$ 500,000
Private Warrants
Subsidiary, Sale of Stock [Line Items]
Gross proceeds			$ 8,900,000
Number of warrants issued			5,933,333
Exercise price of warrants			$ 1.50
Private Warrants | Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	333,334
Exercise price of warrants			11.50
Proceeds from sale of Private Placement Warrants	$ 500,000
Initial Public Offering and Private Placement
Subsidiary, Sale of Stock [Line Items]
Share price per share			$ 10
Maturity period of governments securities			185 days
Aggregate proceeds held in the Trust Account			$ 525,000,000
Class A ordinary shares | Private Placement.
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants			$ 11.50					$ 11.50
Class B ordinary shares | Sponsor | Founder Shares
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price				$ 25,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Equivalents	$ 0	$ 0
Unrecognized tax benefits	0	0
Accrued interest and penalties	0	$ 0
Federal Depository Insurance Corporation coverage	$ 250,000
Class A ordinary shares
Temporary Equity, Shares Outstanding	52,500,000	52,500,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded since their inclusion would be anti-dilutive		23,766,667
Financing cost - derivative warrant liabilities	$ 1,067,843
Change in fair value of warrant liabilities	$ 9,269,010	$ (23,053,670)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of calculation of basic and diluted net income (loss) per ordinary share (Details) - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Numerator: Net income (loss) allocable to Class A ordinary shares
Net gain from investments held in Trust Account	$ 3,144	$ 34,668
Class A ordinary shares
Numerator: Net income (loss) allocable to Class A ordinary shares
Net income (loss)	$ (7,003,588)	$ 16,073,578
Denominator: Weighted average ordinary shares
Basic weighted average shares outstanding	24,744,898	52,500,000
Diluted weighted average shares outstanding	24,744,898	52,500,000
Basic net income per share	$ (0.28)	$ 0.31
Diluted net income per share	$ (0.28)	$ 0.31
Class B ordinary shares
Numerator: Net income (loss) allocable to Class A ordinary shares
Net income (loss)	$ (3,580,013)	$ 4,018,394
Denominator: Weighted average ordinary shares
Basic weighted average shares outstanding	12,648,810	13,125,000
Diluted weighted average shares outstanding	12,648,810	13,125,000
Basic net income per share	$ (0.28)	$ 0.31
Diluted net income per share	$ (0.28)	$ 0.31

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Nov. 27, 2020	Nov. 24, 2020	Oct. 22, 2020	Dec. 31, 2020	Dec. 31, 2021	Oct. 16, 2020
Subsidiary, Sale of Stock [Line Items]
Price per share					$ 10
Proceeds received from initial public offering, gross				$ 525,000,000
Offering costs				7,411,300
Deferred underwriting commissions				$ 12,950,000	$ 12,950,000
Exercise price of warrants					$ 11.50
Cash underwriting fees					$ 6,900,000
Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Ordinary shares, authorized shares				400,000,000	400,000,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued			50,000,000
Price per share			$ 10
Proceeds received from initial public offering, gross			$ 500,000,000
Offering costs			19,600,000
Deferred underwriting commissions			$ 12,100,000
Exercise price of warrants			$ 11.50
Ordinary shares, authorized shares						5,175,000
Gross proceeds			$ 500,000,000
Initial Public Offering | Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of units issued			15,500,000
Initial Public Offering | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit			1
Initial Public Offering | Class A ordinary shares | Public warrants
Subsidiary, Sale of Stock [Line Items]
Number of shares issuable per warrant			1
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of units issued	2,500,000	2,500,000	5,175,000
Price per share			$ 10
Offering costs	$ 1,400,000
Deferred underwriting commissions	$ 900,000
Period granted for underwriters to exercise option			45 days
Unit price	$ 10
Ordinary shares, authorized shares			5,175,000
Gross proceeds	$ 25,000,000
Cash underwriting fees	$ 1,400,000

Private Placement (Details)

Private Placement (Details) - USD ($) $ / shares in Units, $ in Millions	Nov. 27, 2020	Oct. 22, 2020	Dec. 31, 2021	Nov. 22, 2020
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrant			$ 11.50
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			30 days
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		5,933,333
Price of warrants		$ 1.50
Aggregate purchase price		$ 8.9
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Private Placement | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares per warrant		1		1
Exercise price of warrant		$ 11.50		$ 11.50
Sponsor | Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	333,334
Aggregate purchase price	$ 0.5

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details)	Dec. 03, 2020USD ($)shares	Oct. 22, 2020USD ($)shares	Aug. 07, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)	Dec. 31, 2021item$ / sharesshares	Dec. 31, 2020USD ($)shares
Related Party Transaction [Line Items]
Aggregate purchase price | $				$ 25,000		$ 25,000
Sponsor | Founder Shares
Related Party Transaction [Line Items]
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item					20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item					30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences					150 days
Class B ordinary shares
Related Party Transaction [Line Items]
Number of shares subject to forfeiture (in shares)					0	0
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders					20.00%
Class B ordinary shares | Founder Shares
Related Party Transaction [Line Items]
Number of shares subject to forfeiture (in shares)					0	0
Class B ordinary shares | Founder Shares | Over-allotment
Related Party Transaction [Line Items]
Number of shares subject to forfeiture (in shares)			1,875,000
Consideration on shares surrendered | $	$ 0
Class B ordinary shares | Sponsor | Over-allotment
Related Party Transaction [Line Items]
Number of shares surrendered	668,750
Class B ordinary shares | Sponsor | Founder Shares
Related Party Transaction [Line Items]
Aggregate purchase price | $			$ 25,000
Number of shares issued			14,375,000
Number of shares subject to forfeiture (in shares)		1,293,750
Shares Subject To Forfeit Par Value | $ / shares			0.0001
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Number of shares surrendered		581,250
Consideration on shares surrendered | $		$ 0
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares					$ 12

Related Party Transactions - Re

Related Party Transactions - Related Party Loans and Administrative Support Agreement (Details) $ / shares in Units, $ in Thousands	Oct. 22, 2020USD ($)	Aug. 07, 2020USD ($)	Dec. 31, 2021USD ($)$ / shares	Dec. 31, 2021USS ($)	Dec. 31, 2020USD ($)	Dec. 31, 2020USS ($)
Related Party Transaction [Line Items]
Loans from working capital			$ 0		$ 0
Amount agreed to pay to sponsor under administrative support agreement			10,000
Related Party Loans
Related Party Transaction [Line Items]
Proceeds from Related Party Advances		$ 300,000
Repayment of advances from related party	$ 161,000
Maximum loans convertible into warrants			$ 1,500,000
Price of warrants (in dollars per share) | $ / shares			$ 1.50
Loans from working capital				$ 0		$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Nov. 27, 2020	Nov. 24, 2020	Oct. 22, 2020	Oct. 16, 2020	Dec. 31, 2021	Dec. 31, 2020
Other Commitments [Line Items]
Underwriting discount per unit					$ 0.20
Deferred fee per unit					$ 0.35
Deferred underwriting fee paid					$ 12,950,000	$ 12,950,000
Underwriting fee paid					$ 6,900,000
Over-allotment
Other Commitments [Line Items]
Common shares, shares authorized (in shares)			5,175,000
Number of units issued	2,500,000	2,500,000	5,175,000
Unit Price	$ 10
Deferred underwriting fee paid	$ 900,000
Underwriting fee paid	$ 1,400,000
Initial Public Offering.
Other Commitments [Line Items]
Underwriters granted day				45 days
Common shares, shares authorized (in shares)				5,175,000
Number of units issued			50,000,000
Deferred underwriting fee paid			$ 12,100,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details)	12 Months Ended
	Dec. 31, 2021item$ / sharesshares	Dec. 31, 2020shares	Oct. 22, 2020$ / shares
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months
Threshold period for filling registration statement after business combination	15 days
Exercise price of warrant	$ 11.50
Public Warrants expiration term	5 years
Threshold issue price per share	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Number of trading days on which fair market value of shares is reported | item	10
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Adjustment of redemption price of stock based on market value and newly issued price (as a percent)	180.00%
Public warrants
Class of Warrant or Right [Line Items]
Number Of Warrants Shares Outstanding | shares	17,500,000	17,500,000
Private Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrant			$ 1.50
Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants | item	20
Threshold consecutive trading days for redemption of public warrants | item	30
Threshold business days before sending notice of redemption to warrant holders	3 days
Redemption period	30 days
Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 10
Redemption price per public warrant (in dollars per share)	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants | item	20
Threshold consecutive trading days for redemption of public warrants | item	30
Threshold business days before sending notice of redemption to warrant holders	3 days
Threshold trading days determining volume weighted average price	10 days
Fair market value per share	$ 0.361
private placements Member | Private Warrants
Class of Warrant or Right [Line Items]
Number Of Warrants Shares Outstanding | shares	6,266,667	6,266,667

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption (Details)	12 Months Ended
	Dec. 31, 2021USD ($)Vote$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares
Class A ordinary shares
Temporary Equity [Line Items]
Ordinary shares, par value | $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1
Ordinary shares, authorized shares | shares	400,000,000	400,000,000
Number of shares subject to possible redemption | shares	52,500,000	52,500,000
Class A Ordinary Shares subject to redemption
Temporary Equity [Line Items]
Number of shares subject to possible redemption | shares	52,500,000	52,500,000
Gross proceeds	$ 525,000,000
Proceeds allocated to public warrants	(26,425,000)
Class A shares offering costs	(19,938,092)
Accretion of carrying value to redemption value	46,363,092
Class A ordinary shares subject to possible redemption	$ 525,000,000	$ 525,000,000

Shareholders' Deficit - Common

Shareholders' Deficit - Common Stock Shares (Details)	Dec. 03, 2020USD ($)	Aug. 07, 2020shares	Dec. 31, 2021Vote$ / sharesshares	Dec. 31, 2020$ / sharesshares	Oct. 22, 2020shares
Class A ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			400,000,000	400,000,000
Ordinary shares, par value | $ / shares			$ 0.0001	$ 0.0001
Common shares, votes per share | Vote			1
Number of shares subject to possible redemption			52,500,000	52,500,000
Common Stock Shares Issued Including Shares Subject To Redemption			52,500,000	52,500,000
Common Stock Shares Outstanding Including Shares Subject To Redemption			52,500,000	52,500,000
Class A Ordinary Shares subject to redemption
Class of Stock [Line Items]
Number of shares subject to possible redemption			52,500,000	52,500,000
Class A Non-redeemable Ordinary Shares
Class of Stock [Line Items]
Ordinary shares, shares outstanding			0	0
Class B ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			40,000,000	40,000,000
Ordinary shares, par value | $ / shares			$ 0.0001	$ 0.0001
Ordinary shares, shares outstanding			13,125,000	13,125,000
Number of shares subject to forfeiture (in shares)			0	0
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Class B ordinary shares | Founder Shares
Class of Stock [Line Items]
Number of shares subject to forfeiture (in shares)			0	0
Over-allotment
Class of Stock [Line Items]
Common shares, shares authorized (in shares)					5,175,000
Over-allotment | Class B ordinary shares | Founder Shares
Class of Stock [Line Items]
Number of shares subject to forfeiture (in shares)		1,875,000
Shares Surrendered During Period, Value | $	$ 0

Shareholders' Deficit - Preferr

Shareholders' Deficit - Preferred Stock Shares (Details) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Shareholders' Deficit
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Measured on a recurring basis - USD ($)	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Quoted Prices in Active Markets (Level 1)
Assets
Investments held in Trust Account	$ 525,037,813		$ 525,003,145
Quoted Prices in Active Markets (Level 1) | Public warrants
Liabilities
Derivative warrant liabilities	16,275,000		33,250,000
Significant Other Observable Inputs (Level 2)
Assets
Investments held in Trust Account			0
Significant Other Observable Inputs (Level 2) | Public warrants
Liabilities
Derivative warrant liabilities			0
Significant Other Observable Inputs (Level 2) | Private Warrants
Liabilities
Derivative warrant liabilities	5,828,000	$ 5,600,000	0
Significant Other Unobservable Inputs (Level 3)
Assets
Investments held in Trust Account	0		0
Significant Other Unobservable Inputs (Level 3) | Public warrants
Liabilities
Derivative warrant liabilities	0		0
Significant Other Unobservable Inputs (Level 3) | Private Warrants
Liabilities
Derivative warrant liabilities	$ 0		$ 11,906,670

Fair Value Measurements - Trans

Fair Value Measurements - Transfers between levels (Details)	Dec. 31, 2020$ / shares
Volatility
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrants and Rights Outstanding, Measurement Input	25.8
Risk-free rate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.36
Dividend yield
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Significant Other Unobservable Inputs (Level 3) | Share price
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrants and Rights Outstanding, Measurement Input	10.33

Fair Value Measurements - Fair

Fair Value Measurements - Fair value of derivative warrant liabilities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrant liabilities at the beginning	$ 45,156,670
Change in fair value of warrant liabilities	(23,053,670)	$ 9,300,000
Warrant liabilities at the end	22,103,000	45,156,670
Public warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrant liabilities at the beginning	33,250,000
Change in fair value of warrant liabilities	(16,975,000)
Warrant liabilities at the end	16,275,000	33,250,000
Private Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrant liabilities at the beginning	11,906,670
Change in fair value of warrant liabilities	(6,078,670)
Warrant liabilities at the end	$ 5,828,000	$ 11,906,670